Over the last decade, heart failure has risen by more than 900% when it comes to mortality in adults under the age of 45.

People who receive stem cell therapy within a week of their first heart attack have nearly a 60 per cent lower risk of ...

Australian scientists have developed a biosensor that can rapidly detect the heart failure biomarker S100A7 in saliva, ...

As alternatives to intravascular lithotripsy, cutting balloon angioplasty and super-high-pressure non-compliant balloons were noninferior in the Short-CUT and VICTORY trials, as highlighted by the ...

Sika AG is a market leader with strong revenue growth but currently trades at a significant premium and faces structural ...

Recently a relative faced a harrowing differential diagnosis: The fluid in his lungs could be cancerous. We were all worried.

A recent survey from the American Heart Association asked 4,007 adults a series of questions about CKM health and found that ...

"We are headed down the road of increasing development and utilization of devices to treat heart failure," Dr. William ...

In the U.S. alone, more than 6.7 million people have heart failure, a number that is projected to increase to more than 8.5 ...

On Holding (ONON) is upgraded from 'sell' to 'hold' after a 20% stock correction, but shares remain too expensive for a buy.

The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination developed by SQ Innovation, Inc., for treating edema caused by chronic heart ...